BioSpace News Archive

Hands reach out to each other. Handshake. Halftone retro hands. Body parts cut out of newspaper. Hands tied with thread. Shaking hands. Make a deal. Successful agreement. Modern collage

Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody

The deal focuses on ICT01, a monoclonal antibody being tested in acute myeloid leukemia. ImCheck is also developing assets in infectious disease and other oncology indications.

October 22, 2025

·

1 min read

·

Dan Samorodnitsky

Illustration of scales of justice tipping to one side

Job Trends

Most Employers Consider Hiring but Worry About Overqualified Job Candidates: Survey

Seven in 10 U.S. hiring managers say their company usually considers employing overqualified applicants, according to a survey from Express Employment Professionals and The Harris Poll. However, 75% of employers believe such hires struggle to stay motivated in lower-level roles.

October 22, 2025

·

3 min read

·

Angela Gabriel

Antibody-drug conjugate (ADC)

Takeda Bets up to $11.4B for Up To Three Innovent Cancer Assets

For $1.2 billion upfront and up to $10.2 billion in milestones, Takeda will gain access to a bispecific antibody fusion protein targeting both the PD-1 and IL-2 pathways, among other assets.

October 22, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose

October 22, 2025

·

7 min read

Press Releases

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study